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Nerve growth factor (NGF) is considered to be a target-derived survival or differentiation factor for neural crest cells
of the sympathoadrenal lineage. However, exogenous NGF was found to have a positive effect on the size of the
primary sympathetic ganglia (PSG) of the chick embryo, well before sympathetic innervation of the periphery. We
have determined the cellular mechanism of NGF's action on the PSG by quantifying both proliferation and apoptosis.
The proportion of PSG cells in S-phase is nearly double in NGF-treated embryos compared to that in controls, strongly
suggesting that NGF acts as a mitogenic factor. NGF reduced the low level of apoptosis at this stage as well. Since
trkA has not been detected in the avian sympathetic ganglia until later in development, we suggest that these early
effects of exogenous NGF may be mediated by the low-af®nity neurotrophin receptor, p75, which is expressed from
neural crest migration stages. q 1997 Academic Press
INTRODUCTION METHODS
The sympathetic ganglia (SG) in the chick embryo de- NGF (2.5S) was delivered to the embryos as two 1-mg pulses at
velop in two successive stages (results of Tello described stages 17±18 (dripped on the chorioallantoic membrane) and stage
in Levi-Montalcini, 1950). Some neural crest cells migrate 21 (injected into the amniotic cavity). Control embryos received
the same volume of carrier (0.1% albumin in 50 ml PBS). Embryosventrad to reach the dorsal aorta. They there form clusters
were sacri®ced at stage 23, and then ®xed in Bouin's ®xative orof cells by about stage 21. Subsequently, a continuous string
4% paraformaldehyde in PBS, embedded in paraf®n, and seriallyof cells is formed, generating a ``beads-on-a-string'' con®gu-
sectioned.ration of the primary sympathetic ganglia (PSG) by stage 23
The SG were delineated by staining with the HNK-1 antibody(E4). A second wave of migration of sympathetic neurons/
(Lallier and Bronner-Fraser, 1988). The primary sympathetic chainprecursors begins at about stage 25 when cells migrate dor-
at stage 23 is a continuous cord of cells, and the PSG are swellings
sad producing the paravertebral chain of SG. The few cells along this cord. For purposes of quanti®cation, we de®ned a gan-
remaining near the dorsal aorta become the prevertebral glion as beginning and ending when two consecutive sections had
chain of SG. approximately the same low value for cross sectional area (see Fig.
As part of a study of the effect of exogenous nerve growth 4A in Goldstein and Kalcheim, 1991). Volumes were determined
from camera lucida drawings with the aid of a PC as described infactor (NGF) on the development of the spinal preganglionic
Goldstein et al. (1990).sympathetic neurons, its effect on the development of the
For estimation of proliferation, embryos were given a pulse ofPSG was examined (Oppenheim et al., 1982). A 20% in-
bromodeoxyuridine before ®xation, triple stained with anti-HNK-crease in the volume of the cervical PSG was found at stages
1 and anti-BrDU antibodies, and counterstained with hematoxylin24±25 after a pulse of NGF at stage 20. Counts of pyknotic
(Figs. 1A and 1B). This technique is described in detail in Avivi etnuclei showed that reduced cell death was apparently not
al. (1994). Estimation of the numbers of dying cells was performed
responsible for the effect of NGF and the authors stated using nuclear staining with hematoxylin, combined with Fast
that the possibility of NGF enhancing proliferation of the Green to delineate the ganglia. A separate set of control and NGF-
SG cells was not ruled out by their results. We therefore treated embryos was used for these counts; these embryos were
decided to test the possibility of a positive effect of NGF ®xed with paraformaldehyde, which allowed easier distinction be-
tween pycnotic and normal nuclei than in Bouin-®xed materialon PSG cell proliferation directly.
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FIG. 1. Photomicrograph through the primary sympathetic chain ganglion (SG) in segment 5 of the chick embryo. This section is
through the maximum of the ganglion, where it is attached to the spinal nerve. The ganglion and the DRG were delineated by HNK-1
staining (purple reaction product). Another section photographed at higher magni®cation is shown in B, where the brown reaction product
reveals which cells were in S-phase 1 hr before sacri®ce (black arrows), and the nuclei of cells not in S-phase are stained blue with
hematoxylin (white arrows). The intersegmental blood vessel is prominent as well. Bars: in A, 100 mm; in B, 20 mm. Abbreviations: SN,
spinal nerve; DRG, dorsal root ganglion; BV, blood vessel; NT, neural tube. (C±F) Visualization of pyknotic nuclei in PSG at stage 23.
This embryo was ®xed with paraformaldehyde, unlike the Bouin ®xation of the tissue shown in A and B. The healthy nuclei have an
evenly dispersed chromatin and very pale cytoplasm. In contrast, pyknotic nuclei (arrows in C and D) stand out even at low magni®cation
(C) as being intensely basophilic, and their cytoplasm is green. Erythrocytes (E) and mitoses (arrows in F) are clearly distinguished from
the pyknotic nuclei using this means of tissue preparation. Bars: in C, 20 mm; in D±F, 10 mm.
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at their maximal cross section than those in PBS-treated
controls (not shown).
This increase in size is larger than that reported by Oppen-
heim and collaborators (Oppenheim et al., 1982), 80% com-
pared to 20%. This may be due to the different protocols
used for NGF administration. Here two doses of NGF were
given, the ®rst at stage 17/18, preceding the single dose
given by Oppenheim et al. The increased volume of the
ganglia that we observed could have resulted from (1) hyper-
trophy of cells, (2) larger spaces between the cells (lower
density), or (3) increased numbers of cells. Cell counts from
alternate sections revealed that there were 20% more cells
in the PSG of NGF-treated embryos (control, 558.6 { 31.6;
NGF, 457.5{ 29.2) than in controls, and this difference was
signi®cant (P  0.03). Therefore, an increased number of
cells is partially responsible for the larger SG. Since the
increase in cell number was less than the increase in vol-
ume, cells were packed less densely in the PSG of NGF-
treated embryos. This reduction in cells/unit volume could
be the result of either cellular hypertrophy, a well-known
response of neurons to NGF, or larger spaces between cells.
We favor the latter explanation, since (1) most cells in the
FIG. 2. Quantitation of responses of ganglion 5 of the primary PSG are migrating and proliferating and are not likely to
sympathetic chain to NGF. In A, the volume of the PSG in segment begin their growth phase until they colonize the permanent
5 is much larger in NGF (NGF)-treated than that in PBS-treated sympathetic ganglia and (2) we observed that the dorsal
controls (CON). B shows that this increase in volume is due in part migration of the cells of the PSG seemed somewhat preco-
to an increase in cell number in the ganglia. In C, the proliferation cious in these embryos, making larger, more outspread gan-
index (S-phase/total cells, PI) of PSG (shaded bars) and DRG (open glia. NGF has been shown to similarly increase migratory
bars) in NGF-treated and control embryos is shown. The PI in the
activity of Schwann cells in mammalian embryos (Antonsympathetic ganglia is nearly doubled by NGF treatment. In con-
et al., 1994).trast, the PI in DRG 5 is virtually identical in both experimental
groups (DRG data from Geffen and Goldstein, 1996). (D) Reduction
of cell death in the PSG by early NGF treatment by nearly two- NGF Increases Proliferation at Stage 23 in Primarythirds. In all panels, the error bars represent the SEM.
Sympathetic Chain
Two important cellular processes are involved in the con-
trol of cell number: proliferation and apoptosis. We quanti-
(Abbadie et al., 1993; Figs. 1C±1E). Because of their relatively low ®ed each of these to determine which might be responsible
numbers, pyknotic nuclei were counted in every section. No correc- for the increased numbers of cells in NGF-treated PSG.
tion for double counts was made because of the small diameter of First, we estimated proliferation in the PSG by calculating
the pyknotic bodies. All values are expressed as the mean { SEM. a proliferation index (PI), the percentage of cells incorporat-
Statistical signi®cance was determined using Student's t test. ing BrDU of the total number of ganglionic cells. NGF al-
most doubled the PI of PSG cells, from 15.2 { 1.0% in
controls to 28.1 { 0.6% in NGF-treated embryos (Fig. 2B,
P  0.001). In contrast, the PI of DRG cells in the sameRESULTS AND DISCUSSION
segment of these embryos (the majority of which are cycling
precursors at this stage, like the cells in the PSG) was identi-NGF Increases the Volume of the Ganglia of the
cal in both experimental and control embryos (Geffen andPrimary Sympathetic Chain
Goldstein, 1996).
We determined the volume of the PSG in segment 5 of
stage 23 chick embryos that were treated with NGF or car-
NGF Reduces Cell Death in the PSGrier at stages 18 and 21 using the criteria described under
Methods and in Goldstein and Kalcheim (1991). NGF treat- We then prepared a separate group of four NGF- and four
carrier-treated embryos that were processed to accentuatement resulted in an increase of volume of more than 80%
compared to normal embryos (Fig. 2A) (control, 47.4 { 4.0; the pyknotic morphology of apoptotic nuclei (Figs. 1C±1F).
In normal embryos, there was a low level of apoptotic cellsNGF, 86.9 { 4.4, n  10 each NGF and control ganglia), a
difference that was statistically signi®cant (P  0.001). The in the PSG, an average of 31.1 { 5.7 cells/ganglion (n  8).
NGF treatment reduced this low level of apoptosis to lessganglia in NGF-treated embryos were both longer and larger
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than a third of the normal level, 8.4 { 1.6 (n  8, Fig. 2C). normal embryos. A reasonable alternative candidate for the
endogenous factor is NT-3, which is expressed early in de-This is apparently in contrast to Oppenheim et al. (1982)
who did not ®nd such a reduction. This discrepancy may velopment and has been shown to have proliferative effects
on neural crest cells and survival effects on sympatheticbe due to the differences in the developmental stage at
which the analysis was performed (present study stage 23, precursors (reviewed in Lewin and Barde, 1996). We simi-
larly proposed recently that p75 may mediate the prolifera-in contrast to stages 24±25), or improved identi®cation of
pyknotic pro®les using paraformaldehyde rather than Car- tive effect of exogenous NGF on DRG cells in the transient
Frorieps ganglion of the chick (Geffen and Goldstein, 1996).noy ®xation. Since in our hands the absolute number of
pyknotic cells per ganglion, the percentage of pyknotic/nor- It is important to note, however, that alternative mecha-
nisms such as NGF induction of trkA (reviewed in Daviesmal cells, and the pyknotic cells per section (the manner
in which results were expressed by Oppenheim et al.) were et al., 1995) or indirect effects of NGF (Represa and Bernd,
1989) may be responsible for our observations (for discus-reduced by NGF, we believe that the effect was genuine.
The almost doubling of the PI of PSG cells suggests that sion see Geffen and Goldstein, 1996).
The sympathetic ganglia are a widely used experimentalthe increase in proliferation may make a signi®cant contri-
bution to the increase in cell number. It is, of course, possi- system for the examination of the effects of neurotrophins.
It is currently believed that they are entirely independent/ble that NGF could preferentially prevent the apoptosis of
cycling precursors. However, DiCiccio-Bloom et al. (1993) insensitive to NGF at early stages, become responsive to
NT-3, and only later develop a dependence on NGF for sur-have pointed out that rescue of cycling precursors would
be expected to increase the absolute numbers of total and vival (Lewin and Barde, 1996). However, the studies that
led to these conclusions evaluated NGF's effects on survivalS-phase cells rather than modify the proportion of those
cells dividing (estimated by the PI). Our ®nding that NGF and not on proliferation at early stages. In addition, since
the majority of these studies were performed in vitro, thecan modify the PI of cells in sympathetic ganglion supports
the original proposal of Levi-Montalcini and co-workers for situation in the embryo may be different, with unidenti®ed
factors controlling precursor survival, and neurotrophins,a proliferative effect of NGF in sympathetic ganglia (Levi-
Montalcini and Booker, 1960). There were problems with including NGF, modulating proliferation at early stages.
the analytical methods used in their classical experiments,
but the conclusion reached may indeed be partially correct.
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